AVID100 IV
Idiopathic Pulmonary Fibrosis
Clinical trials
1
Developer
Formation Biologics
Overview
AVID100 IV is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 1 tracked IPF clinical trial.
AVID100 IV clinical trials
Explore related
Medical disclaimer. This page summarizes research about AVID100 IV for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.